AzTrials
AzTrials

Horner's SyndromeNCT01958801

Clinical Efficacy of Supraclavicular Block for Arthroscopic Shoulder Surgery

A study testing Supraclavicular block and Interscalene block in people with Horner's Syndrome, run by Daegu Catholic University Medical Center at 1 site in South Korea.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to compare the efficacy of supraclavicular and interscalene brachial plexus blocks in the patients undergoing arthroscopic shoulder surgery. Read more about this study

Who is it for?
Ages 15 to 80 yearsHealthy volunteers can take part
Conditions the study is for
Horner's Syndrome
What is being tested?
Supraclavicular block and Interscalene block
Could I receive a placebo?
No, everyone receives an active treatment
How many people
104 participants
Where
1 siteSouth Korea
Study dates
Sep 2013to Mar 2014
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • American Society of Anesthesiologists physical status I-II
  • Body mass index < 35 kg/m2

Who cannot join

  • Neurologic deficits on the side to be blocked
  • Infection or inflammation at the puncture site for brachial plexus block
  • Psychiatric disorders
  • Patient refusal
  • Difficulty to communicate
  • Coagulation deficiencies

Trial locations and contacts

1 site in 1 country.

South Korea1 site
  • Daegu Catholic University Medical Center

    Daegu, 705-718

Other trials in South Korea

About this study

Official title: Comparison Between Ultrasound-guided Supraclavicular and Interscalene Brachial Plexus Blocks in the Patients Undergoing Arthroscopic Shoulder Surgery

The aim of this study is to compare the efficacy of supraclavicular and interscalene brachial plexus blocks in the patients undergoing arthroscopic shoulder surgery.

Read the detailed description

This study aims to compare supraclavicular brachial plexus block to interscalene brachial plexus block with regard to degree of sensory and motor blockades, side effects and complications of the blocks, and frequency of intraoperative analgesics or antihypertensives use.

Being tested
Supraclavicular block, Interscalene block
Keywords
Supraclavicular brachial plexus block, Interscalene brachial plexus block, Arthroscopic shoulder surgery
Medical subject headings
Horner Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Supraclavicular blockOther

    Redirection of the needle is allowed when spread of local anesthetics does not surround the brachial plexus appropriately and involuntary movement of the forearm or hand is not necessary to confirm the correct placement of the needle.

  • Interscalene blockOther

    Redirection of the needle is allowed when spread of local anesthetics does not surround the brachial plexus appropriately and involuntary movement of the forearm or hand is not necessary to confirm the correct placement of the needle.

Study groups in NCT01958801
Study groupRoleWhat they receive
Interscalene blockActive comparatorInterscalene block is performed under ultrasound guidance. Linear probe is placed on the ipsilateral interscalene groove visualizing the brachial plexus located between anterior and middle scalene muscles. Using in-plane technique, nerve stimulation needle is advanced into the brachial plexus sheath, into which 25 ml of 1.5% mepivacaine is injected.
Receives: Other: Interscalene block
Supraclavicular blockExperimentalSupraclavicular block is performed under ultrasound guidance. Linear probe is placed on the ipsilateral supraclavicular fossa visualizing the brachial plexus located lateral to the subclavian artery. Using in-plane technique, nerve stimulation needle is advanced into the brachial plexus sheath, into which 25 ml of 1.5% mepivacaine is injected.
Receives: Other: Supraclavicular block

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Degree of sensory blockade

    Sensory blockade of the C5 to T1 dermatomes was assessed by rating the absence of cold sensation between 100 (intact sensation) and 0 (no sensation) with an alcohol swab.

    Measured: 20 minutes after the end of local anesthetics injection

Secondary outcomes (3)
  1. Degree of motor blockade

    Motor blockade was evaluated by elbow and wrist extension (radial nerve), finger abduction (ulnar nerve), wrist flexion (median nerve), and elbow flexion (musculocutaneous nerve). The muscle force was rated on a scale of 0 to 6 as follows (6: normal muscle force; 5: slightly reduced muscle force; 4: greatly reduced muscle force; 3: slightly impaired mobility; 2: greatly impaired mobility; 1: near complete paralysis; 0: complete paralysis).

    Measured: 20 minutes after the end of local anethetics injection

  2. Side effects

    Horner's syndrome (ptosis, miosis, anhidrosis) Subjective dyspnea Hoarseness

    Measured: 20 minutes after the end of local anethetics injection

  3. Frequency of intraoperative analgesics or antihypertensives use

    Frequency of intraoperative use of opioids (fentanyl) or antihypertensives (hydralazine)

    Measured: At the end of the surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Oct 2013 (estimated)
  2. Study startSep 2013
  3. Primary completionMar 2014
  4. Study completionMar 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
104 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01958801
Sponsor's protocol ID
CR-13-033
Status last verified
Apr 2014
First submitted
7 Oct 2013
Last updated
8 Apr 2014
Results posted
No
Data monitoring committee
No

Publications

  • Liu SS, Gordon MA, Shaw PM, Wilfred S, Shetty T, Yadeau JT. A prospective clinical registry of ultrasound-guided regional anesthesia for ambulatory shoulder surgery. Anesth Analg. 2010 Sep;111(3):617-23. doi: 10.1213/ANE.0b013e3181ea5f5d. Epub 2010 Aug 4.

    PubMed 20686013
  • Conroy PH, Awad IT. Ultrasound-guided blocks for shoulder surgery. Curr Opin Anaesthesiol. 2011 Dec;24(6):638-43. doi: 10.1097/ACO.0b013e32834c155f.

    PubMed 21934495

Questions about this trial

What is this clinical trial studying?

A study testing Supraclavicular block and Interscalene block in people with Horner's Syndrome, run by Daegu Catholic University Medical Center at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Apr 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Degree of sensory blockade (time frame: 20 minutes after the end of local anesthetics injection). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01958801, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Apr 2014.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in